NIH supports investigator-initiated program projects on infectious and immune-mediated diseases requiring at least two related research projects and an administrative core; clinical trials are not allowed.
Funder: National Institutes of Health
Due Dates: January 25, 2027 (Application) | May 25, 2027 (Application) | September 25, 2027 (Application) | January 25, 2028 (Application) | May 25, 2028 (Application) | September 25, 2028 (Application) | January 25, 2029 (Application) | May 25, 2029 (Application)
Funding Amounts: No budget limit; requests must reflect actual project needs, for up to five years
Summary: NIAID supports integrated, investigator-initiated research programs addressing infectious, immunologic, and allergic diseases.
Key Information: Clinical trials are not allowed; programs require at least two synergistic Research Projects and an Administrative Core.
The National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, supports investigator-initiated Program Project (P01) applications with a well-defined central research focus. Relevant work includes infectious microbe biology and pathogenesis, including HIV; host–microbe interactions; immune development and function across the lifespan; and immune dysfunction involving allergy, asthma, autoimmunity, immunodeficiency, or transplant rejection. Translational research may develop vaccines, therapeutics, and diagnostics to prevent or treat infectious and immune-mediated diseases.
The program supports coordinated research whose shared data, complementary expertise, and resources produce benefits beyond pursuing projects independently. Each Research Project must be a distinct, scientifically meritorious effort led by an independent investigator. Optional Scientific Cores provide services rather than conduct research and must support at least two Research Projects.